Phase 3 doses: 25 mg and 50 mg once daily for induction and maintenance
Fixed dose in ABTECT induction: one capsule daily, no dose adjustment
Maintenance dose strategy: company report of regulatory consultant support for both 25 mg and 50 mg
Dose escalation from 25 mg to 50 mg after relapse in ABTECT maintenance Part 2
Dose de-escalation from 50 mg to 25 mg in the long-term open-label Study 108
Phase 2b dose range: 25 mg, 50 mg, and 100 mg once daily